Drug Profile
CDS PM 101
Alternative Names: CDS PM101Latest Information Update: 20 Nov 2018
Price :
$50
*
At a glance
- Originator pSivida Inc
- Class Opioid analgesics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Postoperative pain
Most Recent Events
- 31 Dec 2008 Discontinued - Phase-I for Postoperative pain in USA (unspecified route)
- 03 Jan 2006 Control Delivery Systems has been acquired by pSivida
- 14 Jun 2004 Phase-I clinical trials in Postoperative pain in USA (unspecified route)